跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMINASE 30 UNITS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EMINASE 30 UNITS
Authorized
STANDARD
EMINASE 30 UNITS
Wellspring Pharmaceutical Canada Corp
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4f421971129ccb52
Company
Wellspring Pharmaceutical Canada Corp
Type
Standard
Approval Details
Approval Id
4f421971129ccb52
Drug Approval Canada Name
EMINASE 30 UNITS
Product Name
EMINASE 30 UNITS
Status
Cancelled Post Market
Status Date
2009-02-23
Original Market Date
1997-12-15
Din
02229390
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:12.20
Atc Original
B01AD03 ANISTREPLASE
Atc Name
b 01 ad 03
Aig Number
0122566002
Company Name
Wellspring Pharmaceutical Canada Corp
Company Address
600, 1741 Lower Water St, Halifax, Nova Scotia, Canada, B3J 0J2
Company Detail Path
/organization/wellspring-pharmaceutical-canada-corp
Company Information
Pharmaceutical Company Name
Wellspring Pharmaceutical Canada Corp
Country Name
Canada
Province Name
Ontario
City Name
oakville,ontario,country_ca
Address
400 Iroquois Shore Rd
Active Ingredients
ANISTREPLASE
30 UNIT / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4f421971129ccb52
Type
Standard
Back to Health Canada Approvals